home / stock / htd / htd news


HTD News and Press, John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest From 08/02/23

Stock Information

Company Name: John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest
Stock Symbol: HTD
Market: NYSE

Menu

HTD HTD Quote HTD Short HTD News HTD Articles HTD Message Board
Get HTD Alerts

News, Short Squeeze, Breakout and More Instantly...

HTD - Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

MENLO PARK, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...

HTD - JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND

JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND PR Newswire NOTICE TO SHAREHOLDERS – SOURCES OF DISTRIBUTION UNDER SECTION 19(a) BOSTON , July 31, 2023 /PRNewswire/ - John Hancock Tax-Advantaged Dividend Income Fund (NYSE: HTD) (the "Fund"), ...

HTD - Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

MENLO PARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 2, 2023. The company will also host a conference call that day at 5:00 p.m. Eastern Time ...

HTD - Corcept's Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)

Phase 1b study demonstrates that miricorilant, a selective cortisol modulator, effectively reduces liver fat, improves liver health and key metabolic and lipid measures and is well-tolerated Corcept will initiate a Phase 2b study in the fourth quarter MENLO PARK, Calif., July 17...

HTD - 3 Closed-End Fund Buys In The Month Of June 2023

2023-07-16 06:10:11 ET Summary In June, the broader indexes headed higher, with more participation outside of only the mega-cap growth names. As usual, I continue to put capital to work every month, but I've also been letting some cash accumulate, too, as the broader indexes conti...

HTD - My Income Portfolio: Risk, Volatility And Mountain Trails

2023-07-03 15:03:27 ET Summary The Beta coefficient measures the behavior of a security relative to the market: a Beta greater than one indicates the investment is more volatile than the market, and vice versa. Standard Deviation, on the other hand, measures the range of an invest...

HTD - HTD: Serviceable Utilities-Focused Equity Fund

2023-06-29 06:40:18 ET Summary The John Hancock Tax-Advantaged Dividend Income Fund primarily invests in dividend-paying equity securities. It has delivered modest long-term returns with higher than benchmark volatility, and its returns appear to be sufficient to fund its distribu...

HTD - HTD: Income And Growth Potential

2023-06-28 14:30:34 ET Summary Investors today are in desperate need of income as inflation has not been dropping nearly as fast as the headlines are leading us to believe. John Hancock Tax-Advantaged Dividend Income Fund invests primarily in utilities and other high-yielding comm...

HTD - Journal of Clinical Oncology Publishes Results of Corcept's Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer

Relacorilant plus nab-paclitaxel improved progression-free survival (PFS), duration of response (DoR) and overall survival (OS), without increasing side effects, compared to nab-paclitaxel monotherapy Confirmatory Phase 3 ROSELLA trial underway, with planned enrollment of 360 patients i...

HTD - How To Become Financially Independent, Stress-Free

2023-06-17 09:00:00 ET Summary Retirees, by the very definition of retirement, need to be financially independent. However, even for folks who are several years away from retirement, it can offer great benefits. We will go over our strategy as to how a diversified income and growt...

Previous 10 Next 10